Trevor M. Polischuk

Trevor M. Polischuk is a Public Equity Partner focused on the global pharmaceutical industry. Previously， he worked at Lehman Brothers as a Senior Research Analyst covering the U.S. pharmaceutical industry. Dr. Polischuk began his career at Warner Lambert as a member of the Pharmaceutical Global Marketing Planning team. In this role， he coordinated marketing activities for the second generation gabapentinoid product， Pregabalin. Dr. Polischuk holds a Doctorate in Neuropharmacology & Gross Human Anatomy from Queen's University and an MBA from Queen's University.